[go: up one dir, main page]

CA2347192A1 - Combinaison pharmaceutique d'ibuprofene-lysine et de domperidone pour traiter la migraine - Google Patents

Combinaison pharmaceutique d'ibuprofene-lysine et de domperidone pour traiter la migraine Download PDF

Info

Publication number
CA2347192A1
CA2347192A1 CA002347192A CA2347192A CA2347192A1 CA 2347192 A1 CA2347192 A1 CA 2347192A1 CA 002347192 A CA002347192 A CA 002347192A CA 2347192 A CA2347192 A CA 2347192A CA 2347192 A1 CA2347192 A1 CA 2347192A1
Authority
CA
Canada
Prior art keywords
domperidone
migraine
ibuprofen
treatment
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002347192A
Other languages
English (en)
Inventor
Stephen G. Mann
Gudola Schirmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Woelm Pharma GmbH and Co
Organon Pharma UK Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2347192A1 publication Critical patent/CA2347192A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention a trait à une combinaison d'ibuprofène lysine et de dompéridone pour traiter et/ou prévenir la migraine, les nausées associées à la migraine, les vomissements et les maux de tête accompagnés de nausées qui font suite à des excès.
CA002347192A 1998-10-13 1999-10-13 Combinaison pharmaceutique d'ibuprofene-lysine et de domperidone pour traiter la migraine Abandoned CA2347192A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9822333.2A GB9822333D0 (en) 1998-10-13 1998-10-13 Pharmaceutical formulation
GB9822333.2 1998-10-13
PCT/GB1999/003398 WO2000021534A1 (fr) 1998-10-13 1999-10-13 Combinaison pharmaceutique d'ibuprofene-lysine et de domperidone pour traiter la migraine

Publications (1)

Publication Number Publication Date
CA2347192A1 true CA2347192A1 (fr) 2000-04-20

Family

ID=10840497

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002347192A Abandoned CA2347192A1 (fr) 1998-10-13 1999-10-13 Combinaison pharmaceutique d'ibuprofene-lysine et de domperidone pour traiter la migraine

Country Status (5)

Country Link
EP (1) EP1121124A1 (fr)
AU (1) AU6219799A (fr)
CA (1) CA2347192A1 (fr)
GB (1) GB9822333D0 (fr)
WO (1) WO2000021534A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
GB0108930D0 (en) * 2001-04-10 2001-05-30 Boots Co Plc Therapeutic agents
US9198889B2 (en) * 2012-09-19 2015-12-01 Quality IP Holdings, LLC Methods for treating post-traumatic stress disorder
US9066953B2 (en) 2012-09-20 2015-06-30 Quality IP Holdings, LLC Methods for increasing endurance and fat metabolism in humans
US8715752B2 (en) 2012-09-20 2014-05-06 Quality Ip Holdings, Inc. Compositions for increasing human growth hormone levels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9702392D0 (en) * 1997-02-06 1997-03-26 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
GB9822333D0 (en) 1998-12-09
EP1121124A1 (fr) 2001-08-08
WO2000021534A1 (fr) 2000-04-20
AU6219799A (en) 2000-05-01

Similar Documents

Publication Publication Date Title
CA2182004C (fr) Comprimes enrobes de paracetamol et de domperidone
UA75047C2 (en) Fixed dose composition of levodopa, carbidopa and entacapone
RU2004117080A (ru) Таблетки тамзулосина с модифицированным высвобождением
JPH02209A (ja) カルビドパ／レボドパの制御放出配合剤
EP2797584B1 (fr) Combinaisons de diacéréine et d'anti-inflammatoires non stéroïdiens
EP1274402A1 (fr) Composition pharmaceutique pour la liberation controlee de paracetamol
AP324A (en) Medicaments for treating inflammatory conditions or for analgiesia.
AU2001260212A1 (en) Composition
KR101370712B1 (ko) 복합 조성물
US5037823A (en) Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
KR100846945B1 (ko) 파라세타몰을 포함하는 연하 정제
US4564614A (en) Antiinflammatory methods
CA2476939A1 (fr) Combinaisons pharmaceutiques d'inhibiteurs de cox-2 et d'opiaces
CA2347192A1 (fr) Combinaison pharmaceutique d'ibuprofene-lysine et de domperidone pour traiter la migraine
JPH0140009B2 (fr)
EP1242092B1 (fr) Combinaison de medicaments destinee au traitement du mal de tete comprenant mirtazapine et un medicament anti-inflammatoire non steroide
CZ79593A3 (en) Antitussive preparation
GB2336999A (en) High-dosage triclosan compositions
AU2001273932A1 (en) Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
JP7656339B2 (ja) 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ
JP2005289905A (ja) 医薬組成物
JPH07501076A (ja) 次サリチル酸ビスマスの単位剤形
AU2013267036B2 (en) Non-steroidal anti-inflammatory drug dosing regimen
KR20210133495A (ko) 옥수수불검화 정량 추출물 및 후박 추출물을 유효성분으로 포함하며 iLet(innovative Low excipient tablet) 기술을 이용한 정제사이즈 축소를 통해 복용 편의성이 향상된 치주질환 예방 또는 치료용 약학적 조성물
BRPI1103205A2 (pt) Composição farmacêutica oral e uso da composição farmacêutica oral

Legal Events

Date Code Title Description
FZDE Discontinued